vTv Therapeutics Inc.VTVTNASDAQ
LOADING
|||
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-17.39%
↓ 25% below average
Average (39q)
-13.95%
Historical baseline
Range
High:174.02%
Low:-494.37%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -17.39% |
| Q2 2025 | -19.48% |
| Q1 2025 | -22.22% |
| Q4 2024 | 28.41% |
| Q3 2024 | -8.64% |
| Q2 2024 | 30.77% |
| Q1 2024 | 29.94% |
| Q4 2023 | 48.93% |
| Q3 2023 | -18.48% |
| Q2 2023 | -24.89% |
| Q1 2023 | 23.53% |
| Q4 2022 | -36.32% |
| Q3 2022 | -18.44% |
| Q2 2022 | 68.21% |
| Q1 2022 | -33.41% |
| Q4 2021 | -494.37% |
| Q3 2021 | -73.17% |
| Q2 2021 | 86.33% |
| Q1 2021 | -419.15% |
| Q4 2020 | 174.02% |
| Q3 2020 | 49.80% |
| Q2 2020 | 41.84% |
| Q1 2020 | 6.25% |
| Q4 2019 | -3.34% |
| Q3 2019 | -9.25% |
| Q2 2019 | -9.02% |
| Q1 2019 | -52.63% |
| Q4 2018 | 4.63% |
| Q3 2018 | 78.82% |
| Q2 2018 | -0.49% |
| Q1 2018 | 31.59% |
| Q4 2017 | -18.13% |
| Q3 2017 | 7.89% |
| Q2 2017 | 6.09% |
| Q1 2017 | -4.19% |
| Q4 2016 | -1.40% |
| Q3 2016 | 11.59% |
| Q2 2016 | -11.68% |
| Q1 2016 | -20.59% |
| Q4 2015 | 29.96% |